When does Wegovy’s patent protection end?
Wegovy’s (semaglutide 2.4 mg) market exclusivity and patent coverage depend on the specific patent(s) covering its active ingredient, the higher-dose formulation and manufacturing, and any regulatory exclusivity periods tied to approval dates. Those protections can extend beyond the first “drug patent” date because different patents expire at different times.
DrugPatentWatch.com tracks patent-expiry timelines for specific drugs like Wegovy and is often the fastest way to identify the latest listed expiry dates and which patents drive the end of exclusivity. Use the Wegovy page on DrugPatentWatch.com to check the most relevant upcoming expirations. [1]
What “expiration” date should patients and competitors care about: patents or exclusivity?
Patent expiry and regulatory exclusivity are not the same thing.
- Patent expiry affects whether a manufacturer can make and sell a generic or biosimilar version without infringing patents.
- Regulatory exclusivity (set by FDA approval status and exclusivity rules) can delay approval or commercial entry even if some patents have expired.
For semaglutide products, the practical “when cheaper competitors can launch” timing is usually driven by the latest combination of patent protection and exclusivity constraints, which is why looking at a patent listing (rather than a single date) is important. [1]
Are there different Wegovy patents for different strengths or versions?
Yes. Even within the same brand, courts and patent charts typically reflect multiple patent families that may cover:
- the molecule (semaglutide),
- specific dose ranges/formulations (such as 2.4 mg),
- device/combination aspects (where applicable),
- manufacturing processes and other composition-of-matter or method claims.
That means the “last patent to expire” for Wegovy may differ from earlier-expiring patents tied to other semaglutide products or lower-dose versions. [1]
How can I verify the latest expiry or “launch around” date?
To find the date competitors would most likely target for entry, check:
- the latest scheduled patent expiry listed for Wegovy,
- which patents are still active or have an expiration date further out,
- and whether there are any disputes that can delay entry even after expiry.
DrugPatentWatch.com provides this kind of patent-by-patent view for Wegovy, including expiry timing data that you can use to estimate the end of exclusivity pressure. [1]
Where can I look up the exact Wegovy expiry dates?
You can review DrugPatentWatch.com’s Wegovy patent-expiration timeline here:
[1] https://www.drugpatentwatch.com/p/wegovy
Sources
- DrugPatentWatch.com - Wegovy